Sage Journals: Discover world-class research

Abstract

Acute respiratory distress syndrome (ARDS) in COVID-19 patients is associated with poor clinical outcomes and high mortality rates, despite the use of mechanical ventilation. Veno-Venous Extracorporeal membrane Oxygenation (VV-ECMO) in these patients is a viable salvage therapy. We describe clinical outcomes and survival rates in 52 COVID-19 patients with ARDS treated with early VV-ECMO at a large, high-volume center ECMO program. Outcomes included arterial blood gases, respiratory parameters, inflammatory markers, adverse events, and survival rates. Patients’ mean age was 47.8 ± 12.1 years, 33% were female, and 75% were Hispanic. At the end of study period, 56% (n = 29) of the patients survived and were discharged and 44% (n = 23) of the patients expired. Survival rate was 75.0% (9 out of 12) in patients placed on ECMO prior to mechanical ventilation. Longer duration on mechanical ventilation prior to ECMO intervention was associated with a 31% (aOR = 1.31, 95% CI, 1.00–1.70) increased odds of mortality after adjusting for age, gender, BMI, number of comorbid conditions, and post-ECMO ventilator days. Early and effective ECMO intervention in critical ill COVID-19 patients might be a valuable strategy in critical care settings to increase their odds of survival.

Keywords

ARDS COVID-19 early ECMO awake ECMO mechanical ventilation observational mortality

Get full access to this article

View all access options for this article.

References

Dong

Gardner

. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 2020; 20(5): 533–534.

Bartlett

Ogino

Brodie

, et al. Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure. ASAIO J 2020; 66(5): 472–474.

Weiss

Murdoch

. Clinical course and mortality risk of severe COVID-19. Lancet 2020; 395(10229): 1014–1015.

Richardson

Hirsch

Narasimhan

, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020; 323: 2052–2059.

Jacobs

Stammers

St Louis

, et al. Extracorporeal membrane oxygenation in the treatment of severe pulmonary and cardiac compromise in coronavirus disease 2019: experience with 32 patients. ASAIO J 2020; 66: 722–730.

Yang

Cai

Luo

, et al. Extracorporeal membrane oxygenation for Coronavirus disease 2019 – induced acute respiratory distress syndrome: a multicenter descriptive study. Crit Care Med 2020; 48: 1289–1295.

Guo

, et al. Extracorporeal membrane oxygenation for coronavirus disease 2019 in Shanghai, China. ASAIO J 2020; 66: 475–481.

Osho

Moonsamy

Hibbert

, et al. Veno-venous extracorporeal membrane oxygenation for respiratory failure in COVID-19 patients: early experience from a major academic medical center in North America. Ann Surg 2020; 272: e75–e78.

World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organization, Geneva, 2020.

10.

Bellani

Laffey

Pham

, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016; 315(8): 788–800.

11.

Combes

Hajage

Capellier

, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 2018; 378(21): 1965–1975.

12.

Giraud

Legouis

Assouline

, et al. Timing of VV-ECMO therapy implementation influences prognosis of COVID-19 patients. Physiol Rep 2021; 9(3): e14715–NaN11.

13.

Fan

Brodie

Slutsky

. Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA 2018; 319: 698–710.

14.

Goligher

Dres

Fan

, et al. Mechanical ventilation-induced diaphragm atrophy strongly impacts clinical outcomes. Am J Respir Crit Care Med 2018; 197(2): 204–213.

15.

Slutsky

Ranieri

. Ventilator-induced lung injury. N Engl J Med 2013; 369: 2126–2136.

16.

Wakabayashi

Wilson

Tatham

, et al. Volutrauma, but not atelectrauma, induces systemic cytokine production by lung-marginated monocytes. Crit Care Med 2014; 42(1): e49–e57.

17.

Halbertsma

Vaneker

Scheffer

, et al. Cytokines and biotrauma in ventilator-induced lung injury: a critical review of the literature. Neth J Med 2005; 63(10): 382–392.

18.

Barbaro

Odetola

Kidwell

, et al. Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med 2015; 191(8): 894–901.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.10 MB

Clinical outcomes of severe COVID-19 patients receiving early VV-ECMO and the impact of pre-ECMO ventilator use

Abstract

Keywords

Get full access to this article

References

Supplementary Material